Navigation Links
Mammogram tool improves some breast cancer detection but also increases false alarms
Date:4/16/2013

(SACRAMENTO, Calif.) -- A costly and widely used mammography add-on increases detection of noninvasive and early-stage invasive breast cancer but also makes more mistakes than mammography alone, researchers from UC Davis and the University of Washington have found.

Published in the April 16 issue of the Annals of Internal Medicine, the study of women enrolled in Medicare is the largest comparison of clinical outcomes of routine screening mammography with and without computer-assisted detection (CAD) -- software developed to enhance the detection of breast cancer during screening mammography.

CAD was most strongly associated in the study with higher incidence of ductal carcinoma in situ (DCIS), a non-invasive breast lesion typically referred to as "stage 0" because it does not affect surrounding tissue or mortality.

"DCIS progresses slowly, if at all," said lead author Joshua Fenton, an associate professor of family and community medicine at UC Davis and a national leader in research to improve the quality of health-care services. "Some of these early noninvasive lesions may never have come to clinical attention in women's lifetimes if CAD were not applied to their mammograms."

CAD also was associated with slightly higher rates of early-stage invasive breast cancer detection.

"There may be benefits if CAD detects early-stage invasive cancer before it progresses," said Fenton. "A longer-term study would be needed to see whether fewer women die of breast cancer on account of the technology."

The study also showed that CAD mammography was associated with increased diagnostic testing, including breast biopsy, among women who did not have breast cancer.

"This means that CAD increases the chances of being unnecessarily called back for further imaging or tests because of a false alarm, which is already a major problem without CAD," said study co-author Joann Elmore, a professor of internal medicine and epidemiology at the University of Washington and specialist in breast cancer screening. "No woman likes receiving a notice saying that there was an abnormality on her mammogram that might or might not be cancer and more testing is necessary. This can understandably be a very stressful experience for women."

CAD algorithms are designed to assist radiologists by marking areas on mammograms that could be associated with breast cancer. Application of CAD has increased rapidly since being approved for Medicare reimbursement in 2001, and it is now used on approximately three out of every four screening mammograms in the U.S. Despite this broad acceptance, some health-care providers have questioned if the benefits of CAD outweigh its annual direct costs to Medicare, which are estimated by Fenton based on CAD prevalence and Medicare reimbursement and enrollment data to exceed $100 million each year.

For the study, Fenton, Elmore and their colleagues analyzed Medicare claims data that were linked with a National Cancer Institute database of cancer diagnoses, treatments and survival. More than 163,000 women nationwide who were 67 to 89 years old when they underwent mammography with or without CAD during 2001 to 2006 were included in the study. The participants received more than 409,000 mammograms -- an average of 2.4 mammograms per person -- during the six-year period.

"The large sample size gave us the opportunity to provide precise estimates of CAD's clinical impact at the national level," said Fenton.

Compared to women screened without CAD, women screened with CAD had a 17 percent increase in diagnoses of noninvasive DCIS breast lesions and a 6 percent increase in diagnoses of early-stage invasive breast cancer. Among women who did not have breast cancer after all, there was a 19 percent increase in additional diagnostic imaging after screening and a 10 percent increase in breast biopsies.

Fenton and Elmore expect their research will inspire debate about the value of Medicare's investment in CAD. They hope their findings also emphasize the need for research to distinguish early-stage breast cancers that are likely to progress from those that are likely to follow a benign course.

"CAD is expensive technology that has been nearly universally adopted in the U.S. due to Medicare's support and the hope that it can help us identify and treat invasive breast cancer early," said Fenton. "Our study suggests that we still don't know whether the benefits outweigh the harms for the average woman on Medicare."


'/>"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916-734-9064
University of California - Davis Health System
Source:Eurekalert

Related medicine news :

1. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
2. False-Positive Mammogram Results May Turn Out Not to Be: Study
3. Here Are the Women Who Need Mammograms in Their 40s: Study
4. No family history not a good reason for women 40-49 to stop yearly screening mammograms
5. Mammograms Beat Thermography for Breast Cancer Detection: Study
6. US mammograms decline after task force recommendation, Mayo Clinic finds
7. Mammograms Have Limited or No Effect on Breast Cancer Deaths: Study
8. Breast Cancer Charity Overstates Value of Mammograms: Researchers
9. Mammograms Do Not Prevent Advanced Breast Cancer, Study Suggests
10. More Cancers May Be Missed Under Latest Mammogram Guidelines
11. Mammogram every 2 years has same benefit as yearly mammogram for older women, UCSF study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... ... Finally, a bruise cream that really works. Originally designed to reduce ... post-surgical treatment plans of a variety of other procedures including, but not limited to, ... bruising and causes a rapid resolution of bruising and inflammatory changes compared to no ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Dr. Seema Daulat, ... Evans Dermatology in the South Lamar location as of July 13, 2016. , Dr. ... School. As a medical student, she regularly volunteered at the Agape Clinic serving Dallas’ ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
Breaking Medicine Technology: